Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18996 | 527 | 27.7 | 57% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
3041 | 2 | PSK//OK 432//IMEXON | 2463 |
18996 | 1 | PSK//POLYSACCHAROPEPTIDE//POLYSACCHARIDE K | 527 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PSK | authKW | 2892353 | 16% | 60% | 83 |
2 | POLYSACCHAROPEPTIDE | authKW | 881306 | 3% | 89% | 17 |
3 | POLYSACCHARIDE K | authKW | 709771 | 3% | 88% | 14 |
4 | CORIOLUS VERSICOLOR | authKW | 699991 | 8% | 29% | 42 |
5 | IMMUNOSUPPRESSIVE ACIDIC PROTEIN | authKW | 536348 | 3% | 51% | 18 |
6 | POLYSACCHARIDE PEPTIDE PSP | authKW | 521467 | 2% | 100% | 9 |
7 | PROTEIN BOUND POLYSACCHARIDE K | authKW | 297979 | 1% | 86% | 6 |
8 | PROTEIN BOUND POLYSACCHARIDE PS K | authKW | 289704 | 1% | 100% | 5 |
9 | PROTEIN BOUND POLYSACCHARIDE K PSK | authKW | 231763 | 1% | 100% | 4 |
10 | YUNZHI | authKW | 231763 | 1% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2902 | 39% | 0% | 205 |
2 | Immunology | 609 | 18% | 0% | 93 |
3 | Pharmacology & Pharmacy | 525 | 20% | 0% | 107 |
4 | Integrative & Complementary Medicine | 342 | 3% | 0% | 17 |
5 | Medicine, Research & Experimental | 246 | 9% | 0% | 48 |
6 | Medical Laboratory Technology | 94 | 2% | 0% | 13 |
7 | Surgery | 38 | 7% | 0% | 36 |
8 | Chemistry, Medicinal | 36 | 3% | 0% | 17 |
9 | Toxicology | 35 | 3% | 0% | 17 |
10 | Gastroenterology & Hepatology | 33 | 3% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BREASTS THYROID PANCREAT SURG | 57941 | 0% | 100% | 1 |
2 | GUNMA ONCOL STUDY GRP | 57941 | 0% | 100% | 1 |
3 | IMOL II | 57941 | 0% | 100% | 1 |
4 | INTERDYSCYPLINARNE NOWOCZESNYCH TECHNOL | 57941 | 0% | 100% | 1 |
5 | MD ANDERSON HOSP TUMOR CELL BIOL | 57941 | 0% | 100% | 1 |
6 | MED BIOREGULAT BIOCHEM HIGASHI KU | 57941 | 0% | 100% | 1 |
7 | MN VET ADM MED MINNE OLIS | 57941 | 0% | 100% | 1 |
8 | ONCOL STUDY GRP | 57941 | 0% | 100% | 1 |
9 | PLANT BIOTECHNOL R D | 57941 | 0% | 100% | 1 |
10 | PLANT BIOTECHNOL R D MORGANTAN INT LIFE SCI | 57941 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER BIOTHERAPY | 15238 | 1% | 5% | 5 |
2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 7662 | 5% | 1% | 24 |
3 | BIOTHERAPY | 7083 | 1% | 2% | 6 |
4 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 6414 | 3% | 1% | 15 |
5 | JAPANESE JOURNAL OF SURGERY | 5491 | 2% | 1% | 9 |
6 | JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY | 4210 | 2% | 1% | 9 |
7 | INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS | 3603 | 1% | 1% | 6 |
8 | JAPANESE JOURNAL OF CANCER RESEARCH | 3187 | 3% | 0% | 14 |
9 | ANTICANCER RESEARCH | 3075 | 6% | 0% | 32 |
10 | GANN | 2784 | 1% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSK | 2892353 | 16% | 60% | 83 | Search PSK | Search PSK |
2 | POLYSACCHAROPEPTIDE | 881306 | 3% | 89% | 17 | Search POLYSACCHAROPEPTIDE | Search POLYSACCHAROPEPTIDE |
3 | POLYSACCHARIDE K | 709771 | 3% | 88% | 14 | Search POLYSACCHARIDE+K | Search POLYSACCHARIDE+K |
4 | CORIOLUS VERSICOLOR | 699991 | 8% | 29% | 42 | Search CORIOLUS+VERSICOLOR | Search CORIOLUS+VERSICOLOR |
5 | IMMUNOSUPPRESSIVE ACIDIC PROTEIN | 536348 | 3% | 51% | 18 | Search IMMUNOSUPPRESSIVE+ACIDIC+PROTEIN | Search IMMUNOSUPPRESSIVE+ACIDIC+PROTEIN |
6 | POLYSACCHARIDE PEPTIDE PSP | 521467 | 2% | 100% | 9 | Search POLYSACCHARIDE+PEPTIDE+PSP | Search POLYSACCHARIDE+PEPTIDE+PSP |
7 | PROTEIN BOUND POLYSACCHARIDE K | 297979 | 1% | 86% | 6 | Search PROTEIN+BOUND+POLYSACCHARIDE+K | Search PROTEIN+BOUND+POLYSACCHARIDE+K |
8 | PROTEIN BOUND POLYSACCHARIDE PS K | 289704 | 1% | 100% | 5 | Search PROTEIN+BOUND+POLYSACCHARIDE+PS+K | Search PROTEIN+BOUND+POLYSACCHARIDE+PS+K |
9 | PROTEIN BOUND POLYSACCHARIDE K PSK | 231763 | 1% | 100% | 4 | Search PROTEIN+BOUND+POLYSACCHARIDE+K+PSK | Search PROTEIN+BOUND+POLYSACCHARIDE+K+PSK |
10 | YUNZHI | 231763 | 1% | 100% | 4 | Search YUNZHI | Search YUNZHI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAEHARA, Y , TSUJITANI, S , SAEKI, H , OKI, E , YOSHINAGA, K , EMI, Y , MORITA, M , KOHNOE, S , KAKEJI, Y , YANO, T , ET AL (2012) BIOLOGICAL MECHANISM AND CLINICAL EFFECT OF PROTEIN-BOUND POLYSACCHARIDE K (KRESTINA (R)): REVIEW OF DEVELOPMENT AND FUTURE PERSPECTIVES.SURGERY TODAY. VOL. 42. ISSUE 1. P. 8-28 | 55 | 74% | 18 |
2 | SUN, C , ROSENDAHL, AH , WANG, XD , WU, DQ , ANDERSSON, R , (2012) POLYSACCHARIDE-K (PSK) IN CANCER - OLD STORY, NEW POSSIBILITIES?.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 5. P. 757-762 | 46 | 87% | 8 |
3 | FISHER, M , YANG, LX , (2002) ANTICANCER EFFECTS AND MECHANISMS OF POLYSACCHARIDE-K (PSK): IMPLICATIONS OF CANCER IMMUNOTHERAPY.ANTICANCER RESEARCH. VOL. 22. ISSUE 3. P. 1737-1754 | 64 | 71% | 91 |
4 | SAKAMOTO, J , MORITA, S , OBA, K , MATSUI, T , KOBAYASHI, M , NAKAZATO, H , OHASHI, Y , (2006) EFFICACY OF ADJUVANT IMMUNOCHEMOTHERAPY WITH POLYSACCHARIDE K FOR PATIENTS WITH CURATIVELY RESECTED COLORECTAL CANCER: A META-ANALYSIS OF CENTRALLY RANDOMIZED CONTROLLED CLINICAL TRIALS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 55. ISSUE 4. P. 404 -411 | 33 | 77% | 45 |
5 | FRITZ, H , KENNEDY, DA , ISHII, M , FERGUSSON, D , FERNANDES, R , COOLEY, K , SEELY, D , (2015) POLYSACCHARIDE K AND CORIOLUS VERSICOLOR EXTRACTS FOR LUNG CANCER: A SYSTEMATIC REVIEW.INTEGRATIVE CANCER THERAPIES. VOL. 14. ISSUE 3. P. 201 -211 | 27 | 77% | 3 |
6 | PIOTROWSKI, J , JEDRZEJEWSKI, T , KOZAK, W , (2015) IMMUNOMODULATORY AND ANTITUMOR PROPERTIES OF POLYSACCHARIDE PEPTIDE (PSP).POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ. VOL. 69. ISSUE . P. 91 -97 | 27 | 75% | 1 |
7 | CUI, T , CHISTI, Y , (2003) POLYSACCHAROPEPTIDES OF CORIOLUS VERSICOLOR: PHYSIOLOGICAL ACTIVITY, USES, AND PRODUCTION.BIOTECHNOLOGY ADVANCES. VOL. 21. ISSUE 2. P. 109 -122 | 29 | 76% | 67 |
8 | TOTH, B , COLES, M , LYNCH, J , (2006) EFFECTS OF VPS EXTRACT OF CORIOLUS VERSICOLOR ON CANCER OF THE LARGE INTESTINE USING A SERIAL SACRIFICE TECHNIQUE.IN VIVO. VOL. 20. ISSUE 3. P. 341-346 | 23 | 85% | 0 |
9 | JIMENEZ-MEDINA, E , BERRUGUILLA, E , ROMERO, I , ALGARRA, I , COLLADO, A , GARRIDO, F , GARCIA-LORA, A , (2008) THE IMMUNOMODULATOR PSK INDUCES IN VITRO CYTOTOXIC ACTIVITY IN TUMOUR CELL LINES VIA ARREST OF CELL CYCLE AND INDUCTION OF APOPTOSIS.BMC CANCER. VOL. 8. ISSUE . P. - | 23 | 74% | 34 |
10 | OHWADA, S , OGAWA, T , MAKITA, F , TANAHASHI, Y , OHYA, T , TOMIZAWA, N , SATOH, Y , KOBAYASHI, I , IZUMI, M , TAKEYOSHI, I , ET AL (2006) BENEFICIAL EFFECTS OF PROTEIN-BOUND POLYSACCHARIDE K PLUS TEGAFUR/URACIL IN PATIENTS WITH STAGE II OR III COLORECTAL CANCER: ANALYSIS OF IMMUNOLOGICAL PARAMETERS.ONCOLOGY REPORTS. VOL. 15. ISSUE 4. P. 861-868 | 23 | 74% | 14 |
Classes with closest relation at Level 1 |